For Pharma
Speed by Default. AI Native to the Core.
One AI-native platform for the full study lifecycle - EDC and eCOA built in, nothing to integrate. Speed that compounds across the portfolio.
Speed by default
The fastest infrastructure for modern trials.
Every phase you compress is a decision reached sooner. Carelane takes the time out of setup, conduct, and lock - not the rigor.
- Days, not months. Protocol to a live, submission-ready study in days, not a build cycle measured in quarters.
- Every phase compresses. AI study build, automated site tasks, and continuous reconciliation pull weeks out of every phase.
- Speed that repeats. Reusable protocol libraries, edit checks, and templates return time on every trial. At your scale, that compounds.
Speed only counts if the data stays clean while you move. That's the point of running it on AI, not around it.
Native AI, not a bolted-on copilot
The AI is part of the infrastructure, not a feature bolted on top.
- Built in, not added on. AI does the study build, the coordination, and the cleaning itself. It's not a chat window next to your EDC - it's the infrastructure underneath.
- Human-in-the-loop on every action. No clinical decision is autonomous.
- Full auditability. Every action logged, timestamped, and attributable - at all times.
“Nobody loses a year to the software. They lose it to wiring the software to everything else.”
Yannick Boerner
CEO, CTO & co-Founder
Carelane
Turn-key, not another integration project
Go live without the integration cycle.
The slowest part of any new platform is rarely the software. It's the year spent wiring it to everything else. Carelane removes that year because the pieces are already one system.
- No integration necessary. EDC and eCOA ship as one system - no middleware, no eighteen-month implementation before first-patient-in.
- One source of truth. No reconciliation gaps, no version drift - quality holds because the data lives in one place.
- Live when you decide. The CSV package and vendor-qualification evidence arrive on day one. No integration project, no lost year.
Empower the teams you have
Your people back on the science.
What buries a pharma team isn't the science - it's the stitching, the chasing, the cleanup.
- Off the tooling, onto the work. Teams stop babysitting systems and get back to the decisions that move a program.
- More studies, same team. Capacity multiplies without the hiring - run more of the portfolio with the people you already have.
- Clean data from day one. No UAT marathon, no end-of-study scramble - audit-ready the moment it's captured.
- Built on open standards. 100% FHIR-native, so what you bring in today doesn't become next year's legacy migration.
At your scale, the compounding effect isn't a feature - it's the whole portfolio moving faster.
Founder-to-Team
Bring one program. We'll show you where the months come out.
Let's chat.
Yannick Boerner
CEO, CTO & co-Founder